Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
Apply
89Zr-DFO-nimotuzumab
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step